Clinical Interchangeability of PD-L1 Immunohistochemistry Assays in First-Line Non–Small Cell Lung Cancer Management With Cemiplimab Internal iliac and obturator lymph nodes are common sites of ...
You wake up. Your AI wakes up. Somewhere, a stranger types a sentence, and your AI listens. This is not science fiction. This ...
Artificial intelligence isn’t just about high-tech hospitals or luxury clinics—it’s changing how and where people get cancer ...
RIT computing students and Professor Rui Li are working on a National Institutes of Health-funded project to use AI in ...
Nearly 50 new cancer therapies are approved every year. This is good news. "But for patients and their treating physicians, it is becoming increasingly difficult to keep track and to select the ...
Machine learning models can help predict which patients receiving systemic therapy for non-small lung cancer are most likely ...
A large language model scans abstracts and titles for signs that an article was produced by a 'paper-mill' company.
Cancer remains one of the leading causes of morbidity and mortality worldwide, characterized by complex genetic and molecular ...
Cancer immunotherapy and chemotherapy are at the forefront of modern cancer treatment, offering significant advancements over traditional methods. Despite ...
Satellite imagery and machine learning (SIML) are increasingly being combined to remotely measure social and environmental outcomes, yet use of this technology has been limited by insufficient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback